EYA4 Gene Cardiomyopathy Dilated Type 1J Genetic Test
At DNA Labs UAE, we offer the EYA4 Gene Cardiomyopathy Dilated Type 1J Genetic Test for the diagnosis and management of this genetic disorder. This test is specifically designed to identify mutations in the EYA4 gene, which is responsible for the weakening and enlargement of the heart muscle.
Test Details
EYA4 gene cardiomyopathy, dilated type 1J is a genetic disorder characterized by the weakening and enlargement of the heart muscle, leading to impaired pumping ability. It is caused by mutations in the EYA4 gene, which provides instructions for producing a protein involved in the development and function of the heart.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the identification of genetic mutations associated with various diseases, including cardiomyopathies. This type of testing can help in the diagnosis and management of EYA4 gene cardiomyopathy, dilated type 1J by identifying specific mutations in the EYA4 gene.
NGS genetic testing involves obtaining a DNA sample, typically through a blood or saliva sample, and sequencing the genetic material to identify any variations or mutations in the EYA4 gene. The results of the test can help determine the presence of EYA4 gene mutations and assist in making a diagnosis, predicting disease progression, and informing treatment decisions.
It is important to note that NGS genetic testing for EYA4 gene cardiomyopathy, dilated type 1J is typically performed by healthcare professionals with expertise in genetics and genetic counseling. The test results should be interpreted in conjunction with clinical findings and family history to provide a comprehensive understanding of the patient’s condition.
Test Components and Price
Test Name: EYA4 Gene Cardiomyopathy Dilated Type 1J Genetic Test
Components: NGS Technology
Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Test Type
Cardiovascular Pneumology Disorders
Doctor
Cardiologist
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for EYA4 Gene Cardiomyopathy, dilated type 1J NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EYA4 Gene Cardiomyopathy, dilated type 1J NGS Genetic DNA Test gene EYA4.
| Test Name | EYA4 Gene Cardiomyopathy dilated type 1J Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for EYA4 Gene Cardiomyopathy, dilated type 1J NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EYA4 Gene Cardiomyopathy, dilated type 1J NGS Genetic DNA Test gene EYA4 |
| Test Details |
EYA4 gene cardiomyopathy, dilated type 1J is a genetic disorder characterized by the weakening and enlargement of the heart muscle, leading to impaired pumping ability. It is caused by mutations in the EYA4 gene, which provides instructions for producing a protein involved in the development and function of the heart. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the identification of genetic mutations associated with various diseases, including cardiomyopathies. This type of testing can help in the diagnosis and management of EYA4 gene cardiomyopathy, dilated type 1J by identifying specific mutations in the EYA4 gene. NGS genetic testing involves obtaining a DNA sample, typically through a blood or saliva sample, and sequencing the genetic material to identify any variations or mutations in the EYA4 gene. The results of the test can help determine the presence of EYA4 gene mutations and assist in making a diagnosis, predicting disease progression, and informing treatment decisions. It is important to note that NGS genetic testing for EYA4 gene cardiomyopathy, dilated type 1J is typically performed by healthcare professionals with expertise in genetics and genetic counseling. The test results should be interpreted in conjunction with clinical findings and family history to provide a comprehensive understanding of the patient’s condition. |
